Provided by Tiger Trade Technology Pte. Ltd.

Benitec Biopharma

11.68
-0.0700-0.60%
Volume:187.58K
Turnover:2.19M
Market Cap:400.10M
PE:-11.07
High:11.79
Open:11.62
Low:11.19
Close:11.75
52wk High:17.15
52wk Low:9.85
Shares:34.25M
Float Shares:20.85M
Volume Ratio:1.14
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0553
EPS(LYR):-1.0472
ROE:-33.50%
ROA:-22.40%
PB:2.14
PE(LYR):-11.15

Loading ...

Oct 18, 2022

Major Issues Report

8-K - Current report
Oct 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 07, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 23, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 16, 2022

Major Issues Report

8-K - Current report
Sep 12, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 09, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 07, 2022

Major Issues Report

8-K - Current report
Sep 02, 2022

Major Issues Report

8-K - Current report
Sep 02, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 11, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 10, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 08, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 29, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 16, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]